Article
04 Aug 2025
Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
31 Jul 2025
Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime
Article
20 Jun 2025
Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials
Article
23 Dec 2024
Novel Biosimilar Anti-Trust Complaint Involving Janssen's STELARA (Ustekinumab) Dismissed By The Canadian Competition Tribunal
Article
23 Dec 2024
Federal Court Of Appeal: No Single Or Mandatory Approach To Obviousness; Prior Art Disclosing Multiple Options Can Anticipate
Article
19 Dec 2024
Federal Court Of Appeal: Patented Medicine Prices Review Board "Crashed" Through "Guardrails" In Attempt To Regulate Unpatented Medicine
Article
05 Nov 2024
Appealing Briefs - Episode 12: Democracy Watch (Podcast)
Article
29 Aug 2024
JAMP Launches Novel Competition Complaint Alleging Janssen Abused Its Dominance Over Stelara (Ustekinumab)
Article
12 Apr 2024
Practical Lessons From NCS Multistage Inc v. Kobold Corporation
Article
28 Mar 2024
Federal Court Of Appeal Patent Update: Google LLC v. Sonos Inc.